Lv3
266 积分 2023-05-19 加入
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
12小时前
待确认
Current strategies in extending half-lives of therapeutic proteins
3天前
已完结
An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability
3天前
已完结
Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress
8天前
已完结
50 years of amino acid hydrophobicity scales: revisiting the capacity for peptide classification
14天前
已完结
Ranibizumab
17天前
已完结
Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. Wilson
17天前
已完结
Robust deep learning–based protein sequence design using ProteinMPNN
1个月前
已完结
De novo design of tunable, pH-driven conformational changes
1个月前
已完结
Whole Cell Panning with Phage Display
3个月前
已完结